Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity

The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia. We reported comparative in vitro studies of combination effects of different cephalosporins (i.e., cefazolin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Microbiol
Päätekijät: Tang, Hung-Jen, Lai, Chih-Cheng, Chen, Chi-Chung, Zhang, Chun-Cheng, Weng, Tzu-Chieh, Yu, Wen-Liang, Chen, Hung-Jui, Chiu, Yu-Hsin, Ko, Wen-Chien, Chuang, Yin-Ching
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2017
Aiheet:
Microbiology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5435797/
https://ncbi.nlm.nih.gov/pubmed/28572795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2017.00884
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia